Federal Coverage of Weight-Loss Drugs Could Bloat National Debt, CBO Says

Medicare coverage of anti-obesity medications (AOM) — now CMS approved for cardiac patients — could drive up the federal deficit over the next decade, according to a new report issued by the Congressional Budget Office (CBO).
Source: Drug Industry Daily